Pharmaengine Inc. and Sentinel Oncology Ltd. have synthesized Wee1-like protein kinase (Wee1) inhibitors and proteolysis targeting chimera (PROTAC) compounds reported to be useful for the treatment of ...
The collaboration operates within a fully transparent 𝐝𝐞𝐬𝐢𝐠𝐧–𝐦𝐚𝐤𝐞–𝐭𝐞𝐬𝐭–𝐚𝐧𝐚𝐥𝐲𝐳𝐞 (𝐃𝐌𝐓𝐀) framework that integrates AI-driven molecular design, rapid compound synthesis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results